Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY TO ASSESS THE INFLUENCE OF ESTETROL (E4) ON HAIR PARAMETERS IN POSTMENOPAUSAL WOMEN (PILOT STUDY)

Next Previous
Trial Profile

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY TO ASSESS THE INFLUENCE OF ESTETROL (E4) ON HAIR PARAMETERS IN POSTMENOPAUSAL WOMEN (PILOT STUDY)

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 08 Oct 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Estetrol (Primary)
  • Indications Female pattern baldness
  • Focus Adverse reactions; Proof of concept; Therapeutic Use
  • Acronyms Hair Study; PILOT STUDY
  • Sponsors Estetra SPRL

Most Recent Events

  • 28 Feb 2024 According Mithra Pharmaceuticals media release, top-line results for this study are expected by Q1 2025.
  • 20 Jan 2022 New trial record
  • 14 Jan 2022 According Mithra Pharmaceuticals media release, to this study will be launched in 2022.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top